Your OGXI calculations are correct. My valuation spreadsheet (much less intricate than yours...) shows about a $75m enterprise valuation. http://www.biotechduediligence.com/stocks.html
I recently bought some OGXI just about the $12 offering price based on valuation and upcoming ogx-427 ASCO data.
Opinions and comments may have been previously posted @BioDueDiligence, at www.biotechduediligence.com, or disseminated to Chimera Research Group subscribers.